ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,894 Cr | ₹2,009 Cr | ₹16,851 Cr | ₹1,347 Cr | ₹1,212 Cr |
What is the latest Revenue of ERIS LIFESCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,894 Cr |
| Mar2025 | ₹2,009 Cr |
| Mar2024 | ₹16,851 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹1,212 Cr |
How is Revenue of ERIS LIFESCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,894 Cr | 44.02 | |
| Mar2025 | ₹2,009 Cr | -88.08 | |
| Mar2024 | ₹16,851 Cr | 1,151.00 | |
| Mar2023 | ₹1,347 Cr | 11.15 | |
| Mar2022 | ₹1,212 Cr | - | |
Compare Revenue of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,581.6 Cr | 5% | 19% | -10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 5% |
19% |
-10.3% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses